The Times Australia
Fisher and Paykel Appliances
The Times World News

.

I’m considering allergen immunotherapy for my hay fever. What do I need to know?

  • Written by Paxton Loke, Paediatric Allergist and Immunologist, Murdoch Children's Research Institute
I’m considering allergen immunotherapy for my hay fever. What do I need to know?

Allergic rhinitis, commonly referred to as hay fever, is a common allergic disorder affecting up to one in five Australians[1]. Symptoms include itchy nose and eyes, excessive sneezing or clear nasal discharge and nasal congestion.

When severe or untreated, hay fever can affect your quality of life[2], resulting in poor sleep, impaired learning, and difficulty in concentrating at school or work.

People with hay fever usually use over-the-counter antihistamines as required. For recurrent or frequent symptoms, corticosteroid nasal sprays are preventive medications readily available over the counter, and are most effective when used regularly.

However, if you continue to have severe and troubling symptoms[3], you might be considering allergen immunotherapy[4], also known as allergen desensitisation.

Read more: Lush grasslands, higher allergy risks – what hay fever sufferers can expect from another La Niña season[5]

Remind me, what happens when you get hay fever?

Hay fever triggers an exaggerated immune response[6] to otherwise harmless airborne allergens such as grass pollen, house dust mite or animal dander. These can end up on the lining of the nose and eyes, which causes irritation.

When encountering these allergens as foreign molecules, the immune system generates proteins, called antibodies. These antibodies are able to accurately recognise that particular molecule as foreign.

In people with hay fever, a particular type of antibody[7], called IgE, is generated. These allergen-specific IgE antibodies then “prime” or prepare cells in the lining of the nose and eyes to recognise and trigger allergic responses when exposed to these allergens.

When the “primed” cells contact the allergen, they release stored molecules, such as histamine. Histamine acts on neighbouring cells to trigger symptoms such as itch, sneeze and runny nose.

Over time, the ongoing stimulation by the allergen will trigger a chronic response[8]. This leads to nasal congestion and tissue swelling of the nasal, or eye lining.

Man uses nasal spray
For some people, nasal sprays don’t provide enough relief. Shutterstock[9]

How does allergen immunotherapy work?

The first step is to ask your GP for a referral to an allergist or clinical immunologist to discuss the best treatment for you.

Your allergist or clinical immunologist will begin by identifying your triggers. This can be done through skin prick tests when you visit the allergy clinic, or through blood tests that detect and measure the proteins (antibodies) that underpin the allergic response.

Allergen immunotherapy dampens[10] the exaggerated response to a specific allergen. It does this by developing cells and antibodies that block rather than activate the immune response against a particular allergen.

Read more: Sneezing with hay fever? Native plants aren't usually the culprit[11]

How is it administered?

Allergen immunotherapy is administered by either injections under the skin (subcutaneous) or drops, tablets or wafers placed under the tongue (sublingual).

The treatment is started by an allergist in the clinic. Injection allergen immunotherapy may then be administered regularly by your GP, usually monthly, while sublingual allergen immunotherapy is taken daily at home.

Patients commonly ask which treatment is better. Research indicates both[12] are effective strategies to minimise the allergic symptoms. For an individual, the choice should depend on a number of patient factors such as asthma, expected tolerability, and, importantly, time constraints (for example, the time it takes to see a GP).

While allergen immunotherapy for children can start as young as five years of age[13], parents should discuss the best treatment for their child with the allergist. Some children may not tolerate regular injections, while others are unable to hold the tablet under the tongue.

How much does it cost?

The cost vary depending on product as allergen immunotherapy products are not subsidised under the PBS.

The sublingual allergen immunotherapy products costs about A$120-$150 per month.

The injection costs about A$600-1200 per year (approximately A$50-100 per month).

How long does it take to work?

The allergist will determine the best time to start allergen immunotherapy, as some products would be preferable to start before spring (for example, grass pollen immunotherapy).

Effective allergen immunotherapy should minimise the allergic symptoms after re-exposure to the allergen. However, this immune “reset” does not have an immediate effect. Patients on allergen immunotherapy typically only notice improved symptoms after six to 12 months.

Person with red eyes
Hay fever is an allergic response causing symptoms such as itchy eyes. Erik Mclean[14]

Patients who undergo treatment should expect symptom improvement within the first year, although there may be continued gradual improvements over future years of treatment.

Allergen immunotherapy may also help reduces asthma flare ups[15] in people diagnosed with the condition who also get hay fever. It’s particularly effective in preventing asthma flares driven by turbulent weather storms[16], also known as thunderstorm asthma[17].

Allergen immunotherapy may also decrease the chance of children with hay fever developing asthma[18].

What are the side effects?

Allergen immunotherapy through sublingual or injections may typically cause local allergic symptoms such as itch, tingling tongue/mouth or localised redness or pain at the injection site.

Significant side effects from both allergen immunotherapy routes are very rare[19], and can include a severe allergic reaction, particularly if you have asthma. Patients with asthma should only start allergen immunotherapy if and when their asthma is well-controlled.

Read more: Do I have COVID or hay fever? Here’s how to tell[20]

How long do improvements last?

For effective allergen immunotherapy, patients should receive gradual and regular administration of the trigger allergen(s) for at least three years[21].

The clinical benefits from allergen immunotherapy are not indefinite, but allergen immunotherapy administered regularly over three to five years will help prolong the sustained response[22] over at least two to three years after stopping.

During this period, patients should have at least yearly reviews with their specialist to ensure the treatment is working and there are no issues with side effects.

References

  1. ^ one in five Australians (www.aihw.gov.au)
  2. ^ quality of life (pubmed.ncbi.nlm.nih.gov)
  3. ^ severe and troubling symptoms (pubmed.ncbi.nlm.nih.gov)
  4. ^ allergen immunotherapy (www.allergy.org.au)
  5. ^ Lush grasslands, higher allergy risks – what hay fever sufferers can expect from another La Niña season (theconversation.com)
  6. ^ exaggerated immune response (link.springer.com)
  7. ^ particular type of antibody (pubmed.ncbi.nlm.nih.gov)
  8. ^ chronic response (pubmed.ncbi.nlm.nih.gov)
  9. ^ Shutterstock (www.shutterstock.com)
  10. ^ dampens (www.ncbi.nlm.nih.gov)
  11. ^ Sneezing with hay fever? Native plants aren't usually the culprit (theconversation.com)
  12. ^ both (pubmed.ncbi.nlm.nih.gov)
  13. ^ five years of age (www.allergy.org.au)
  14. ^ Erik Mclean (unsplash.com)
  15. ^ reduces asthma flare ups (pubmed.ncbi.nlm.nih.gov)
  16. ^ preventing asthma flares driven by turbulent weather storms (pubmed.ncbi.nlm.nih.gov)
  17. ^ thunderstorm asthma (www.allergy.org.au)
  18. ^ asthma (pubmed.ncbi.nlm.nih.gov)
  19. ^ very rare (pubmed.ncbi.nlm.nih.gov)
  20. ^ Do I have COVID or hay fever? Here’s how to tell (theconversation.com)
  21. ^ least three years (pubmed.ncbi.nlm.nih.gov)
  22. ^ sustained response (pubmed.ncbi.nlm.nih.gov)

Read more https://theconversation.com/im-considering-allergen-immunotherapy-for-my-hay-fever-what-do-i-need-to-know-190408

Times Magazine

Can bigger-is-better ‘scaling laws’ keep AI improving forever? History says we can’t be too sure

OpenAI chief executive Sam Altman – perhaps the most prominent face of the artificial intellig...

A backlash against AI imagery in ads may have begun as brands promote ‘human-made’

In a wave of new ads, brands like Heineken, Polaroid and Cadbury have started hating on artifici...

Home batteries now four times the size as new installers enter the market

Australians are investing in larger home battery set ups than ever before with data showing the ...

Q&A with Freya Alexander – the young artist transforming co-working spaces into creative galleries

As the current Artist in Residence at Hub Australia, Freya Alexander is bringing colour and creativi...

This Christmas, Give the Navman Gift That Never Stops Giving – Safety

Protect your loved one’s drives with a Navman Dash Cam.  This Christmas don’t just give – prote...

Yoto now available in Kmart and The Memo, bringing screen-free storytelling to Australian families

Yoto, the kids’ audio platform inspiring creativity and imagination around the world, has launched i...

The Times Features

The rise of chatbot therapists: Why AI cannot replace human care

Some are dubbing AI as the fourth industrial revolution, with the sweeping changes it is propellin...

Australians Can Now Experience The World of Wicked Across Universal Studios Singapore and Resorts World Sentosa

This holiday season, Resorts World Sentosa (RWS), in partnership with Universal Pictures, Sentosa ...

Mineral vs chemical sunscreens? Science shows the difference is smaller than you think

“Mineral-only” sunscreens are making huge inroads[1] into the sunscreen market, driven by fears of “...

Here’s what new debt-to-income home loan caps mean for banks and borrowers

For the first time ever, the Australian banking regulator has announced it will impose new debt-...

Why the Mortgage Industry Needs More Women (And What We're Actually Doing About It)

I've been in fintech and the mortgage industry for about a year and a half now. My background is i...

Inflation jumps in October, adding to pressure on government to make budget savings

Annual inflation rose[1] to a 16-month high of 3.8% in October, adding to pressure on the govern...

Transforming Addiction Treatment Marketing Across Australasia & Southeast Asia

In a competitive and highly regulated space like addiction treatment, standing out online is no sm...

Aiper Scuba X1 Robotic Pool Cleaner Review: Powerful Cleaning, Smart Design

If you’re anything like me, the dream is a pool that always looks swimmable without you having to ha...

YepAI Emerges as AI Dark Horse, Launches V3 SuperAgent to Revolutionize E-commerce

November 24, 2025 – YepAI today announced the launch of its V3 SuperAgent, an enhanced AI platf...